IRIX
IRIX
NASDAQ · Health Care

Iridex Corp

$0.99
-0.36 (-26.67%)
Financial Highlights (FY 2026)
Revenue
37.32M
Net Income
-6,832,443
Gross Margin
40.1%
Profit Margin
-18.3%
Rev Growth
-3.4%
D/E Ratio
1.31
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 40.1% 40.1% 56.3% 56.3%
Operating Margin -17.1% -15.4% 13.1% 16.3%
Profit Margin -18.3% -17.4% 13.2% 10.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 37.32M 38.61M 9.46M 8.84M
Gross Profit 14.95M 15.47M 5.33M 4.98M
Operating Income -6,367,010 -5,928,928 1.24M 1.45M
Net Income -6,832,443 -6,362,336 1.25M 954.2K
Gross Margin 40.1% 40.1% 56.3% 56.3%
Operating Margin -17.1% -15.4% 13.1% 16.3%
Profit Margin -18.3% -17.4% 13.2% 10.8%
Rev Growth -3.4% -3.4% +21.4% +18.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 4.82M 4.82M 6.66M 8.89M
Total Equity 3.69M 3.69M 19.95M 18.01M
D/E Ratio 1.31 1.31 0.33 0.49
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -6,331,986 -6,223,886 2.05M 1.75M
Free Cash Flow 641.3K 670.3K